Monte Rosa Therapeutics Inc (GLUE)

8.48 -0.15 (-1.74%) USD  |  NASDAQ  |  Nov 14, 16:00
8.48 0.00 (0.00%) After-Hours: 05:51
More

Monte Rosa Therapeutics EV to Assets (Quarterly)

EV to Assets (Quarterly) Chart

View EV to Assets (Quarterly) for GLUE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EV to Assets (Quarterly) Data

View and export this data back to 2024. Upgrade now.
Date Value
June 30, 2024 --
Date Value
March 31, 2024 --

Enterprise Value Ratios (EV) Definition

Enterprise Value/Financial Metrics are often used by analysts to quickly look at a company's valuation multiples. All things being equal, the lower this ratio is, the better.

Read full definition.

EV to Assets (Quarterly) Range, Past 5 Years

Upgrade
Minimum
Jun 2024
Upgrade
Maximum
Mar 2024
Upgrade
Average
Upgrade
Median

EV to Assets (Quarterly) Benchmarks

Novartis AG Upgrade
MEI Pharma Inc Upgrade
Evoke Pharma Inc Upgrade
Revance Therapeutics Inc Upgrade
Vera Therapeutics Inc --

EV to Assets (Quarterly) Related Metrics

EV to Free Cash Flow Upgrade